Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4876
PUT
Innoviva
INVA
$1.51B
| $65K | ﹤0.01% |
3,600
-1,834,500
| -100% | -$31.5M |
|
4877
PUT
Navient
NAVI
$852M
| $65K | ﹤0.01% |
3,600
| – | – |
|
4878
Tucows
TCX
$157M
| $65K | ﹤0.01% |
+2,400
| New | +$54.4K |
|
|
ATW
4879
CALL
DELISTED
Atwood Oceanics
ATW
| $65K | ﹤0.01% |
2,500
-1,500
| -38% | -$46.1K |
|
|
CHMT
4880
DELISTED
Chemtura Corporation
CHMT
| $65K | ﹤0.01% |
2,326
-30,854
| -93% | -$912K |
|
|
BEBE
4881
DELISTED
Bebe Stores Inc
BEBE
| $65K | ﹤0.01% |
3,211
+2,853
| +797% | +$80.5K |
|
|
FSYS
4882
DELISTED
FUEL SYSTEMS SOLUTIONS INC COM STK
FSYS
| $65K | ﹤0.01% |
9,307
-2,311
| -20% | -$21.5K |
|
|
PPO
4883
PUT
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $65K | ﹤0.01% |
1,100
| – | – |
|
4884
CALL
Hovnanian Enterprises
HOV
$808M
| $64K | ﹤0.01% |
1,276
+488
| +62% | +$38.4K |
|
4885
CALL
Matthews International
MATW
$857M
| $64K | ﹤0.01% |
+1,200
| New | +$61.2K |
|
4886
NovaGold Resources
NG
$3.02B
| $64K | ﹤0.01% |
21,453
+9,641
| +82% | +$36.6K |
|
|
SBR
4887
Sabine Royalty Trust
SBR
$1.03B
| $64K | ﹤0.01% |
1,710
| – | – |
|
4888
CALL
CVR Partners
UAN
$1.34B
| $64K | ﹤0.01% |
530
+470
| +783% | +$64.3K |
|
4889
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.7B
| $64K | ﹤0.01% |
996
-31
| -3% | -$2.01K |
|
4890
Acadia Pharmaceuticals
ACAD
$4.93B
| $63K | ﹤0.01% |
1,546
-1,771
| -53% | -$68.5K |
|
4891
WisdomTree International AI Enhanced Value Fund
AIVI
$63.4M
| $63K | ﹤0.01% |
1,500
| – | – |
|
4892
CALL
Buckle
BKE
$2.34B
| $63K | ﹤0.01% |
1,400
-4,900
| -78% | -$226K |
|
4893
Compugen
CGEN
$216M
| $63K | ﹤0.01% |
10,586
+8,270
| +357% | +$57.9K |
|
4894
PUT
Commault Systems
CVLT
$5.52B
| $63K | ﹤0.01% |
1,500
+400
| +36% | +$18.1K |
|
|
HI
4895
PUT
DELISTED
Hillenbrand
HI
| $63K | ﹤0.01% |
2,100
+500
| +31% | +$15.4K |
|
4896
Kemper
KMPR
$1.72B
| $63K | ﹤0.01% |
1,677
-10,604
| -86% | -$400K |
|
4897
CALL
LKQ Corp
LKQ
$6.1B
| $63K | ﹤0.01% |
2,100
-6,600
| -76% | -$183K |
|
4898
PUT
Madrigal Pharmaceuticals
MDGL
$11.9B
| $63K | ﹤0.01% |
903
+517
| +134% | +$43.4K |
|
4899
PUT
ProShares Ultra Gold
UGL
$709M
| $63K | ﹤0.01% |
6,800
-5,600
| -45% | -$54K |
|
|
SQNM
4900
CALL
DELISTED
SEQUENOM INC NEW
SQNM
| $63K | ﹤0.01% |
20,900
+8,700
| +71% | +$32.7K |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.